Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinoma
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier BV in Neoplasia
- Vol. 23 (6), 584-593
- https://doi.org/10.1016/j.neo.2021.05.005
Abstract
No abstract availableFunding Information
- Bristol-Myers Squibb Co
- German Research Foundation
This publication has 42 references indexed in Scilit:
- Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung AdenocarcinomaClinical Lung Cancer, 2013
- Ly6/uPAR-Related Protein C4.4A as a Marker of Solid Growth Pattern and Poor Prognosis in Lung AdenocarcinomaJournal of Thoracic Oncology, 2013
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironmentCurrent Opinion in Immunology, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX studyThe Lancet Oncology, 2012
- The Ca2+-dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-κB ActivationOnline Journal of Public Health Informatics, 2011
- Prognostic value of a biologic classification of non-small-cell lung cancer into the growth patterns along with other clinical, pathological and immunohistochemical factors☆European Journal of Cardio-Thoracic Surgery, 2010
- A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I TumorsThe American Journal of Surgical Pathology, 2010
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cellsBlood, 2008
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002